Vikas Gupta - 08 Jan 2026 Form 4 Insider Report for OMEGA HEALTHCARE INVESTORS INC (OHI)

Role
Chief Investment Officer
Signature
/s/ Meghan C. Lyons, Attorney-in-Fact
Issuer symbol
OHI
Transactions as of
08 Jan 2026
Net transactions value
$0
Form type
4
Filing time
12 Jan 2026, 16:15:12 UTC
Previous filing
02 Jan 2026
Next filing
15 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gupta Vikas Chief Investment Officer 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY /s/ Meghan C. Lyons, Attorney-in-Fact 12 Jan 2026 0002051514

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OHI Profits Interest Units Award $0 +59,449 +184% $0.000000 91,686 08 Jan 2026 OP Units 59,449 Direct F1, F2, F3
transaction OHI Profits Interest Units Award $0 +22,480 +25% $0.000000 114,166 08 Jan 2026 OP Units 22,480 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one (1) unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. OP Units do not expire.
F2 The PIUs have been earned, but not yet vested, based on Absolute Total Shareholder Return for the 2023-2025 performance period, as certified by the Compensation Committee as of January 8, 2026.
F3 25% of the PIUs earned based on the 2023-2025 performance period will vest at the end of each quarter of 2026, subject to continued employment and accelerated vesting upon certain events.
F4 The PIUs have been earned, but not yet vested, based on Relative Total Shareholder Return for the 2023-2025 performance period, as certified by the Compensation Committee as of January 8, 2026.